For the second time in 6 months, the Centers for Medicare & Medicaid Services officials have revised readmission penalties for hospitals. In doing so, approximately 1200 hospitals are now subject to lesser penalties.
For the second time in 6 months, the Centers for Medicare & Medicaid Services (CMS) officials have revised readmission penalties for hospitals. In doing so, approximately 1200 hospitals are now subject to lesser penalties.
The new corrections include decreased penalties for 1246 hospitals and increased penalties for 226 hospitals, resulting in a total of $280 million in penalties, which is approximately $10 million less than previously calculated. Kaiser Health News also released the following information following an analysis of the new data:
According to Jonathan Blum, Acting Principal Deputy Administrator and Director, Center for Medicare and CMS, stated that “This decrease is an early sign that our payment and delivery reforms are having an impact.” Kaiser Health News adds that “Under the program, the government is looking at the number of heart attack, heart failure, and pneumonia patients who return to the hospital within 30 days of discharge,” and that “hospitals with more readmissions than Medicare expected given their mix of patients are penalized by losing up to 1% of their regular payments.”
Around the Web
Medicare Revises Readmissions Penalties — Again [Kaiser Health News]
CMS Revises Hospitals' Readmission Penalties for the Second Time [Becker’s Hospital Review]
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More